CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced the appointment of Farzad (Zod) Nazem to the NextBio Board of Directors.
“As the former Chief Technology Officer at Yahoo!, Zod gained tremendous expertise in building highly scalable systems to deal with large and ever-growing volumes of information. This experience will be extremely valuable to NextBio as we create new systems to deal with the rising mountain of genomic data and its efficient use in life science research, drug discovery and clinical development, and ultimately, personalized medicine,” said Saeid Akhtari, NextBio President and Chief Executive Officer. “In addition, his experience in growing Oracle and Yahoo from small to very large, industry leading companies will be an important business resource for us as NextBio enters its next stage of growth.
“We are clearly entering the next stage of the genomics revolution as researchers and drug developers begin to apply this data to improve the clinical development and use of drugs,” said Farzad Nazem. “I am excited about NextBio’s potential to play a leading role in bringing about the effective use of genomics data for preventive, personalized medicine.”
Mr. Nazem served as Yahoo!’s Chief Technology Officer from 1996 until his retirement in 2007. He is credited with building the massively scalable and cost-effective site operations that allowed 600 million users to make Yahoo! their home in cyberspace. Prior to joining Yahoo! Mr. Nazem spent 11 years with Oracle Corporation as Vice President of the Media and Web Server Division and a member of the Product Division’s Management Committee. Prior to Oracle, he held various technical positions at Sydis, Inc. and Rolm Corporation. He earned a B.S. degree in Computer Science with highest honors from California Polytechnic State University.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio's platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. NextBio's unique 'correlation engine' pre-computes billions of significant connections among public and private data and enables researchers to intelligently mine it in real-time. NextBio helps organizations increase productivity and dramatically improve collaboration across therapeutic groups and geographic boundaries. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
Today, NextBio is used by researchers at the world's top commercial and academic institutions. NextBio's enterprise solution has been deployed at Burnham Institute for Medical Research, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Merck, Regeneron, Scripps Research Institute, Stanford University, UCB, and Takeda, among many others. To learn more about NextBio, please visit our website at http://www.nextbio.com.